Lily L Nguyen
6PUBLICATIONS
42CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 04, 2025
SM08502-Mediated β-Catenin Repression Synergizes with Olaparib to Inhibit Tumor Progression.Bradley R Corr, Elizabeth R Woodruff, Tomomi M Yamamoto
|Aug 13, 2024
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent Manner.Lily L Nguyen, Zachary L Watson, Raquel Ortega
|Jul 10, 2024
Tumor-Intrinsic Activity of Chromobox 2 Remodels the Tumor Microenvironment in High-grade Serous Carcinoma.Ritsuko Iwanaga, Tomomi M Yamamoto, Karina Gomez
|Jun 12, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.Lily L Nguyen, Zachary L Watson, Raquel Ortega
|May 07, 2024
Combining EHMT and PARP Inhibition: A Strategy to Diminish Therapy-Resistant Ovarian Cancer Tumor Growth while Stimulating Immune Activation.Lily L Nguyen, Zachary L Watson, Raquel Ortega
|Sep 23, 2022
ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian Cancer.Alexandra McMellen, Tomomi M Yamamoto, Lubna Qamar
Pageof 1
Frequent Collaborators
6 joint publications
Tomomi M Yamamoto
6 joint publications
Benjamin G Bitler
5 joint publications
Elizabeth R Woodruff
5 joint publications
Edward B Chuong
4 joint publications
Ritsuko Iwanaga
4 joint publications
Kimberly R Jordan
4 joint publications
Kian Behbakht
3 joint publications
Zachary L Watson
3 joint publications
Courtney A Bailey
3 joint publications
Raquel Ortega
